"Kstandi" is an anti-tumor drug that blocks the action of male hormones. The main active ingredient is enzalutamide (40 mg per capsule). The drug is available in pharmacies with a prescription.

The capsules come in a pack of 112.

How the drug works: "Kstandi" inhibits the activity of androgen hormones, such as testosterone. This slows down the growth and division of cancer cells in the prostate gland.

Suitable for whom**

Kstandi is intended for adult men over the age of 18 with:

• castration-resistant prostate cancer (CRPC);
• metastatic hormone-sensitive prostate cancer (mmHg).

When you can not take

The drug is contraindicated in:

• allergies to enzalutamide or other components;
• pregnancy and lactation (due to the risk to the fetus).

It is prescribed with caution in case of severe renal insufficiency.

How to take

The usual dose is 160 mg (4 capsules of 40 mg) once a day.

Rules of reception:

• Capsules are swallowed whole with water, regardless of food.
• Do not chew, dissolve or open.
• Taken daily at the same time.

If you miss a dose, take as soon as possible. If you forget for a whole day, start treatment the next day with the usual dose.

Important: treatment should be carried out under the supervision of an oncologist.

Possible side effects

When taking Kstandi, the following may occur:

• Headache, memory impairment, loss of attention, restless leg syndrome.
• Hot flashes, increased blood pressure.
• Dry skin, itching.
• Bone fractures.
• Fatigue, weakness, and falls.

Consult your doctor before starting this product.